One of the most challenging years for pharma on record is coming to a close. Though COVID-19 is still causing widespread disruption and claiming lives, we’re now a step closer to ending this chapter of history. With more vaccine candidates edging closer to approval, optimism is in the air. This month, we’ve taken a look back at the key events that have defined this period and the innovation that has emerged as a result. We’re also celebrating the innovative products and companies who have found ways to shine, despite the setbacks that have become synonymous with 2020. You’ll find all of this and more below.
Until next time, Maryam Mahdi, Associate Editor
|